Literature DB >> 16777573

Concepts and epidemiology of spondyloarthritis.

Joachim Sieper1, Martin Rudwaleit, Muhammed Asim Khan, Jürgen Braun.   

Abstract

The term 'spondyloarthritides' (SpA) comprises ankylosing spondylitis (AS), reactive arthritis, arthritis/spondylitis with inflammatory bowel disease, and arthritis/spondylitis with psoriasis. The main links between these diseases are an association with HLA-B27 and a similar clinical picture. Patients normally present with chronic low back pain or asymmetrical arthritis, predominantly of the lower limbs, and an overlap of these symptoms often occurs. AS is regarded as the most severe subtype. Recent attention has focused on earlier diagnosis of AS among patients with chronic low back, and this is becoming more important as effective therapies for early treatment have become available. AS is a disease of young people, normally starting in the third decade of life. The incidence and prevalence rates of AS, and of SpA as a whole, are strongly dependent and are directly correlated to the prevalence of HLA-B27 in a given population. Incidence rates of 0.5-8.2/100 000 population and prevalence rates of 0.2-1.2% have been described for AS, and about double these figures have been reported for SpA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777573     DOI: 10.1016/j.berh.2006.02.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  74 in total

Review 1.  The transition of acute to chronic bowel inflammation in spondyloarthritis.

Authors:  Liesbet Van Praet; Peggy Jacques; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

Review 2.  Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions.

Authors:  Nicholas Bhojwani; Peter Szpakowski; Sasan Partovi; Martin H Maurer; Ulrich Grosse; Hendrik von Tengg-Kobligk; Lisa Zipp-Partovi; Nathan Fergus; Christos Kosmas; Konstantin Nikolaou; Mark R Robbin
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 3.  Clinical observations programme in SpA: disease parameters, treatment options and practical management issues.

Authors:  Dirk Elewaut; Filip Van den Bosch; Gust Verbruggen; Filip de Keyser; Bert Vander Cruyssen; Herman Mielants
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

4.  Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism.

Authors:  Zhen Wu; Zhiming Lin; Qiujing Wei; Jieruo Gu
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

Review 5.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

6.  High frequencies of HLA-B27 in Chinese patients with suspected of ankylosing spondylitis.

Authors:  Xiang Liu; Yi-Rong Li; Li-Hua Hu; Zhi-Ming Zhou; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

7.  Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis.

Authors:  Consuelo Romero-Sánchez; William H Robinson; Beren H Tomooka; John Londoño; Rafael Valle-Oñate; Feng Huang; Xiaohu Deng; Liyun Zhang; Chunhua Yang; David Tak Yan Yu
Journal:  Clin Rheumatol       Date:  2008-06-20       Impact factor: 2.980

8.  Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.

Authors:  Bahiri Rachid; Bassel El Zorkany; Ehab Youseif; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2012-08-19       Impact factor: 2.980

9.  Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Authors:  Carmen Stolwijk; Marieke Pierik; Robert Landewé; Ad Masclee; Astrid van Tubergen
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

10.  Treatment of ankylosing spondylitis: focus on etanercept.

Authors:  Tracy Frech
Journal:  Biologics       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.